Kailera Therapeutics, Inc. KLRA
13.89 USD +0.92 (+7.09%)
Nov 9, 2026, 11:27 AM EST
13.01 Day range 14.07
9.76 52-week range 28.23
- YTD
- -46.58%
- 1 year
- -46.58%
Held by funds
69 US ETFs and mutual funds hold KLRA · largest positions
Ownership
Held by insiders 8.91%
Held by institutions 90.64%
Float held by institutions 99.51%
Institutions 162
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Bain Capital Investors Llc | 20.25% | 26,255,581 | 340.53M | Jun 29, 2026 |
| Bain Capital Life Sciences Investors, LLC | 17.42% | 22,583,268 | 292.90M | Jun 29, 2026 |
| RTW Investments LP | 8.31% | 10,776,820 | 139.78M | Jun 29, 2026 |
| Canada Pension Plan Investment Board | 5.63% | 7,304,688 | 94.74M | Jun 29, 2026 |
| Atlas Venture Life Science Advisors, LLC | 3.99% | 5,171,282 | 67.07M | Jun 29, 2026 |
| FMR, LLC | 3.06% | 3,970,865 | 51.50M | Jun 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| VANGUARD SPECIALIZED FUNDS-Vanguard Health Care Fund | 1.69% | 2,191,928 | 28.43M | Jul 30, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 1.28% | 1,657,199 | 21.49M | Sep 29, 2026 |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 0.94% | 1,221,869 | 15.85M | Sep 29, 2026 |
| iShares Trust-iShares Russell 2000 ETF | 0.93% | 1,199,783 | 15.56M | Sep 29, 2026 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 0.91% | 1,180,411 | 15.31M | Jun 29, 2026 |
| T. Rowe Price Health Sciences Fund, Inc. | 0.70% | 904,283 | 11.73M | Jun 29, 2026 |
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| BAIN CAPITAL INVESTORS, L.L.C. | Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Apr 19, 2026 | 2,034,130 |
| KAPLAN ANDREW T | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| KOPPEL ADAM M | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 19, 2026 | 0 |
| RENAUD RONALD C JR | Chief Executive Officer | Conversion of Exercise of derivative security | Jun 8, 2026 | 38,094 |